NuGen M.D. Commences Trading on OTCQB Under The Symbol 'NGMDF'

Rhea-AI Summary

NuGen Medical Devices Inc. has commenced trading on the OTCQB under the symbol NGMDF, effective July 27, 2022. This marks a significant milestone, enhancing the accessibility for American investors. The company continues to trade on the TSX Venture Exchange under the symbol NGMD. NuGen is also awaiting approval for DTC eligibility, facilitating electronic settlement and transfer of shares in the U.S. The company specializes in needle-free medical devices, including the InsuJet™ and PetJet™, targeting diabetes, veterinary medicine, and vaccines.

Positive

• Trading on OTCQB enhances accessibility for American investors.
• DTC eligibility approval will facilitate easier share transactions in the U.S.

Negative

• None.

TORONTO, ON / ACCESSWIRE / July 27, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce that, effective July 27, 2022, its common shares will commence trading on the OTCQB under the symbol NGMDF. The Company's common shares will continue to trade on the TSX Venture Exchange in Canada under the symbol "NGMD".

"Commencing trading on the OTCQB venture exchange is an important milestone for NuGen," stated Michael Wright, CEO of NuGen. "Having our common shares available on the OTCQB will increase accessibility for American investors interested in directly participating in NuGen's growth with the same ease as their Canadian counterparts."

The OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on www.otcmarkets.com.

The Company also reports that it is awaiting approval for its application for DTC eligibility through the Depository Trust Company for electronic settlement and transfer of its common shares in the United States.

About NuGen Medical Devices

NuGen is an emerging specialty medical device company developing the next generation of needle-free technologies and other innovative medical delivery products. The company's products, which include the InsuJet™ and PetJet™ needle-free injection systems, are designed to improve the lives of millions of people and animals. NuGen continues to receive approval in numerous countries, including Canada. NuGen's products are designed for use in several important fields including, but not limited to, diabetes, veterinary medicine, and vaccines.

For More Information visit: www.nugenmd.com
Twitter: @NuGenMD
LinkedIn: https://www.linkedin.com/company/nugenmd/

For further information, please contact:
Michael Wright
President and CEO
NuGen Medical Devices Inc.
mw@nugenmd.com

Investor Relations Contact:
Kin Communications Inc.
NGMD@kincommunications.com
(604) 684-6730

Twitter: @KinComm

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ from those projected in the forward-looking statements. Forward looking statements in this press release include the Company's 2022 objectives of securing additional distribution and sales agreements, making submissions for regulatory approvals and capitalizing on additional market opportunities. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.

SOURCE: NuGen Medical Devices

View source version on accesswire.com:
https://www.accesswire.com/709954/NuGen-MD-Commences-Trading-on-OTCQB-Under-The-Symbol-NGMDF

FAQ

What is the significance of NuGen Medical Devices trading on OTCQB?

Trading on OTCQB increases accessibility for American investors, allowing them to participate in NuGen's growth more easily.

What is the stock symbol for NuGen Medical Devices on the OTCQB?

The stock symbol for NuGen Medical Devices on the OTCQB is NGMDF.

When did NuGen Medical Devices start trading on OTCQB?

NuGen Medical Devices commenced trading on the OTCQB on July 27, 2022.

What products does NuGen Medical Devices offer?

NuGen offers needle-free injection systems like InsuJet™ and PetJet™, targeting diabetes, veterinary medicine, and vaccines.

Is NuGen Medical Devices pursuing DTC eligibility?

Yes, NuGen is awaiting approval for DTC eligibility to facilitate electronic settlement and transfer of shares in the U.S.